Lv7210
4860 积分 2024-07-23 加入
Nerandomilast (Jascayd) for idiopathic pulmonary fibrosis
6小时前
已完结
Psoriatic patients with cancer: a multicentric real-life study comparing Risankizumab and Apremilast
3天前
已完结
A new liver-targeted agonist of thyroid hormone receptor beta resmetirom in treating MASLD/MASH: From mechanism to therapy
6天前
已完结
Precision Modulation of the PDE4 Pathway: The Emerging Role of Nerandomilast in Pulmonary Fibrosis
8天前
已完结
Icotrokinra (Icotyde) for psoriasis
8天前
已关闭
Divergent effect of diabetes on fibrosis response to semaglutide and resmetirom in noncirrhotic MASH: A meta-analysis of randomized trials
16天前
已关闭
Pharmacologic Treatments for MASLD: A Review of Efficacy and Safety Considerations
16天前
已完结
‘Resmetirom for metabolic steatohepatitis: implications for clinical practice’
16天前
已完结
Effectiveness and Safety of Apremilast in Immune Checkpoint Inhibitor‐Associated Psoriasis: A Retrospective Multicenter Study From the EADV Task Force “Dermatology for Cancer Patients”
23天前
已完结
Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial
23天前
已完结
皖公网安备34019202002308
